Background: Depression and obesity are widespread and closely linked. Brain-derived neurotrophic factor (BDNF) and vitamin D are both assumed to be associated with depression and obesity. Little is known about the interplay between vitamin D and BDNF. We explored the putative associations and interactions between serum BDNF and vitamin D levels with depressive symptoms and abdominal obesity in a large population-based cohort. Methods: Data were obtained from the population-based Study of Health in Pomerania (SHIP)-Trend (n = 3,926). The associations of serum BDNF and vitamin D levels with depressive symptoms (measured using the Patient Health Questionnaire) were assessed with binary and multinomial logistic regression models. The associations of serum BDNF and vitamin D levels with obesity (measured by the waist-to-hip ratio [WHR]) were assessed with binary logistic and linear regression models with restricted cubic splines. Results: Logistic regression models revealed inverse associations of vitamin D with depression (OR = 0.966; 95% CI 0.951–0.981) and obesity (OR = 0.976; 95% CI 0.967–0.985). No linear association of serum BDNF with depression or obesity was found. However, linear regression models revealed a U-shaped association of BDNF with WHR (p < 0.001). Conclusion: Vitamin D was inversely associated with depression and obesity. BDNF was associated with abdominal obesity, but not with depression. At the population level, our results support the relevant roles of vitamin D and BDNF in mental and physical health-related outcomes.

Keywords:
Brain-derived neurotrophic factor, Vitamin D, Depression, Obesity
1.
Haslam DW, James WPT: Obesity. Lancet 2005; 366: 1197–1209.
2.
World Health Organization: Fact sheet: depression 2018. http://www.who.int/news-room/fact-sheets/detail/depression (accessed April 24, 2018).
3.
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, et al: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220–229.
4.
Hajiluian G, Nameni G, Shahabi P, Mesgari-Abbasi M, Sadigh-Eteghad S, Farhangi MA: Vitamin D administration, cognitive function, BBB permeability and neuroinflammatory factors in high-fat diet-induced obese rats. Int J Obes 2017; 41: 639–644.
5.
Ozer AB, Demirel I, Erhan OL, Firdolas F, Ustundag B: Effect of different anesthesia techniques on the serum brain-derived neurotrophic factor (BDNF) levels. Eur Rev Med Pharmacol Sci 2015; 19: 3886–3894.
6.
Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry J-M: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143–148.
7.
Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BWJH, Elzinga BM: Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (n = 9,484). Mol Psychiatry 2014; 19: 791–800.
8.
Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, et al: Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012; 7:e42676.
9.
Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN, et al: Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000; 470: 113–117.
10.
Nockher WA, Renz H: Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation. Clin Chim Acta Int J Clin Chem 2005; 352: 49–74.
11.
Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, et al: Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728–734.
12.
Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry J-M, Bertschy G: Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068–1072.
13.
Chacón-Fernández P, Säuberli K, Colzani M, Moreau T, Ghevaert C, Barde Y-A: Brain-derived neurotrophic factor in megakaryocytes. J Biol Chem 2016; 291: 9872–9881.
14.
Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, et al: Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 2009; 39: 1425–1432.
15.
Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, et al: Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 264–270.
16.
Ferreira ST, Clarke JR, Bomfim TR, De Felice FG: Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 2014; 10:S76–S83.
17.
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415.
18.
Noble EE, Billington CJ, Kotz CM, Wang C: The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 2011; 300:R1053–R1069.
19.
Park H-K, Ahima RS: Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 2015; 64: 24–34.
20.
El-Gharbawy AH, Adler-Wailes DC, Mirch MC, Theim KR, Ranzenhofer L, Tanofsky-Kraff M, et al: Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab 2006; 91: 3548–3552.
21.
Monteleone P, Tortorella A, Martiadis V, Serritella C, Fuschino A, Maj M: Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 2004; 66: 744–748.
22.
Suwa M, Kishimoto H, Nofuji Y, Nakano H, Sasaki H, Radak Z, et al: Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 2006; 55: 852–857.
23.
Nakazato M, Hashimoto K, Shimizu E, Kumakiri C, Koizumi H, Okamura N, et al: Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 2003; 54: 485–490.
24.
Kok P, Seidell JC, Meinders AE: The value and limitations of the body mass index [BMI] in the assessment of the health risks of overweight and obesity. Ned Tijdschr Geneeskd 2004; 148: 2379–2382.
25.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al: Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518: 197–206.
26.
Lee CMY, Huxley RR, Wildman RP, Woodward M: Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008; 61: 646–653.
27.
Ganji V, Zhang X, Tangpricha V: Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the US population based on assay-adjusted data. J Nutr 2012; 142: 498–507.
28.
González-Gross M, Valtueña J, Breidenassel C, Moreno LA, Ferrari M, Kersting M, et al: Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br J Nutr 2012; 107: 755–764.
29.
Mithal A, Wahl DA, Bonjour J-P, Burckhardt P, Dawson-Hughes B, Eisman JA, et al: Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807–1820.
30.
Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S–1688S.
31.
Kerr DCR, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF: Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 2015; 227: 46–51.
32.
Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al: The association between low vitamin D and depressive disorders. Mol Psychiatry 2014; 19: 444–451.
33.
Anglin RES, Samaan Z, Walter SD, McDonald SD: Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 2013; 202: 100–107.
34.
Jääskeläinen T, Knekt P, Suvisaari J, Männistö S, Partonen T, Sääksjärvi K, et al: Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr 2015; 113: 1418–1426.
35.
Patrick RP, Ames BN: Vitamin D hormone regulates serotonin synthesis. 1. Relevance for autism. FASEB J 2014; 28: 2398–2413.
36.
Wrzosek M, Łukaszkiewicz J, Wrzosek M, Jakubczyk A, Matsumoto H, Piątkiewicz P, et al: Vitamin D and the central nervous system. Pharmacol Rep 2013; 65: 271–278.
37.
Lapin IP, Oxenkrug GF: Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1969; 293: 132–136.
38.
Eyles DW, Burne THJ, McGrath JJ: Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 2013; 34: 47–64.
39.
Kesby JP, Eyles DW, Burne THJ, McGrath JJ: The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 2011; 347: 121–127.
40.
Leedahl DD, Cunningham JL, Drake MT, Mundis CB, Kung S, Frye MA, et al: Hypovitaminosis D in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practices. Psychosomatics 2013; 54: 257–262.
41.
Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T: Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362–369.
42.
Hannemann A, Thuesen BH, Friedrich N, Völzke H, Steveling A, Ittermann T, et al: Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark. Nutr Metab 2015; 12: 24.
43.
Pereira-Santos M, Costa PRF, Assis AMO, Santos CST, Santos DB: Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 2015; 16: 341–349.
44.
Snijder MB, van Dam RM, Visser M, Deeg DJH, Dekker JM, Bouter LM, et al: Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119–4123.
45.
Earthman CP, Beckman LM, Masodkar K, Sibley SD: The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 2012; 36: 387–396.
46.
John PDU, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, et al: Study of Health in Pomerania (SHIP): a health examination survey in an east German region – objectives and design. Soz Präventivmed 2001; 46: 186–194.
47.
Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al: Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011; 40: 294–307.
48.
Grabe HJ, Lange M, Wolff B, Völzke H, Lucht M, Freyberger HJ, et al: Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2004; 10: 220–224.
49.
Manea L, Gilbody S, McMillan D: A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry 2015; 37: 67–75.
50.
Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613.
51.
Skrbo A, Zulić I, Hadzić S, Gaon ID: Anatomic-therapeutic-chemical classification of drugs (in Croatian). Med Arh 1999; 53: 57–60.
52.
German Society for Sports Medicine and Prevention: S-1 Leitlinie Vorsorgeuntersuchung im Sport. Frankfurt am Main, DGSP, 2007.
53.
German Nutrition Society: New reference values for vitamin D. Ann Nutr Metab 2012; 60: 241–246.
54.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.
55.
Serra-Millàs M: Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation? World J Psychiatry 2016; 6: 84–101.
56.
Hashimoto K: Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010; 64: 341–357.
57.
Woo NH, Teng HK, Siao C-J, Chiaruttini C, Pang PT, Milner TA, et al: Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8: 1069–1077.
58.
Huang C-J, Mari DC, Whitehurst M, Slusher A, Wilson A, Shibata Y: Brain-derived neurotrophic factor expression ex vivo in obesity. Physiol Behav 2014; 123: 76–79.
59.
Gajewska E, Sobieska M, Łojko D, Wieczorowska-Tobis K, Suwalska A: Obesity itself does not influence BDNF serum levels in adults. Eur Rev Med Pharmacol Sci 2014; 18: 3246–3250.
60.
Lebrun B, Bariohay B, Moyse E, Jean A: Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton Neurosci 2006; 126–127: 30–38.
61.
Timpano KR, Schmidt NB, Wheaton MG, Wendland JR, Murphy DL: Consideration of the BDNF gene in relation to two phenotypes: hoarding and obesity. J Abnorm Psychol 2011; 120: 700–707.
62.
Mueller K, Arelin K, Möller HE, Sacher J, Kratzsch J, Luck T, et al: Serum BDNF correlates with connectivity in the (pre)motor hub in the aging human brain-a resting-state fMRI pilot study. Neurobiol Aging 2016; 38: 181–187.
63.
Winker R, Lukas I, Perkmann T, Haslacher H, Ponocny E, Lehrner J, et al: Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM). Wien Klin Wochenschr 2010; 122: 704–716.
64.
Verduijn J, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, Penninx BWJH: Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psychiatry 2015; 5:e649.
65.
Pirotta S, Kidgell DJ, Daly RM: Effects of vitamin D supplementation on neuroplasticity in older adults: a double-blinded, placebo-controlled randomised trial. Osteoporos Int 2015; 26: 131–140.
66.
Ju S-Y, Lee Y-J, Jeong S-N: Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. J Nutr Health Aging 2013; 17: 447–455.
67.
Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100–105.
68.
Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K: Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008; 264: 599–609.
69.
Humble MB: Vitamin D, light and mental health. J Photochem Photobiol B 2010; 101: 142–149.
70.
Mellenthin L, Wallaschofski H, Grotevendt A, Völzke H, Nauck M, Hannemann A: Association between serum vitamin D concentrations and inflammatory markers in the general adult population. Metabolism 2014; 63: 1056–1062.
71.
Lerchbaum E: Vitamin D and menopause: a narrative review. Maturitas 2014; 79: 3–7.
72.
LeBlanc ES, Rizzo JH, Pedula KL, Ensrud KE, Cauley J, Hochberg M, et al: Associations between 25-hydroxyvitamin D and weight gain in elderly women. J Womens Health 2012; 21: 1066–1073.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.